外来睡眠ポリグラフ（PSG）システム市場：製品別、用途別、エンドユーザー別：世界の機会分析と産業予測、2022-2031年

外来睡眠ポリグラフ（PSG）システム市場は2021年に3億2,700万米ドルで、2022年から2031年にかけてCAGR 6%で成長し、2031年には5億7,070万米ドルに達すると推定されます。

外来睡眠ポリグラフ（Ambulatory polysomnography：Amb-PSG）は、タイプII PSGとしても知られ、睡眠段階を特徴付け、覚醒、総睡眠時間（TST）、正確な呼吸障害指数（RDI）を定量化することで、さまざまな睡眠障害を特定するために使用できます。外来睡眠ポリグラフ検査システムは、その利点から、さまざまな睡眠障害を患う患者の間で高い需要があります。これが、外来睡眠ポリグラフ（PSG）システム市場を促進しています。

人口の大多数、特に地方では、睡眠時無呼吸症候群の危険性について知らされていないです。睡眠障害が治療されないまま放置されると、心不全、脳卒中、高血圧、糖尿病、肥満などの慢性疾患につながる可能性があります。その結果、血圧がコントロールできなくなったり、心臓発作を起こしたり、腎臓の血管が弱って制限されたり、動脈瘤ができたりといった大きな健康問題を引き起こす可能性があります。睡眠障害に対する国民の認識不足は、近い将来、外来睡眠ポリグラフ検査システム市場の成長を妨げると予想されます。

睡眠ケア事業における技術改善は、この市場の推進力として特定できます。外来睡眠ポリグラフ（PSG）システム市場は、ポータブルデバイス、スマートフォンアプリケーション、遠隔医療など、数多くの革新的な技術によって着実に成長しています。Nox MedicalのNox A1s PSGのようなワイヤレスでポータブルな睡眠ポリグラフ検査システムは、研究開発の恩恵を受けています。ワイヤレス機能は、診断中に患者が自由に動けるようにすることで、患者に開放感を与えます。これは外来睡眠ポリグラフ（PSG）システム市場の成長に有益な影響を与えると思われます。

世界市場はCOVID-19パンデミックの発生によって恩恵を受けた。主要参加者は、COVID-19パンデミックの結果、睡眠障害に苦しむ患者数が増加した結果、収益が大幅に伸びたと主張しています。世論調査によると、回答者の70％がCOVID-19の開始以来、1つ以上の新たな睡眠問題を経験し、睡眠時無呼吸装置の使用増加につながりました。この結果、PSGシステムの事業者は、臨床的に認定された、患者の自宅から遠隔操作で利用できるロータッチCPAPマスク選択ツールを発売しました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

• 市場の定義と範囲
• 主な調査結果
  • 影響要因
  • 主な投資機会
• ポーターのファイブフォース分析
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• COVID-19市場への影響分析
• 平均販売価格
• ブランドシェア分析
• 主要規制分析
• 市場シェア分析
• 特許情勢
• 規制ガイドライン
• バリューチェーン分析

第4章 外来睡眠ポリグラフ（PSG）システム市場：製品別

• 概要
• 12チャンネル未満PSGシステム
• 24チャンネル未満PSGシステム
• 32チャンネル未満PSGシステム
• 32チャンネル以上

第5章 外来睡眠ポリグラフ（PSG）システム市場：用途別

• 概要
• 閉塞性睡眠
• 無呼吸ナルコレプシー
• 慢性不眠症
• その他

第6章 外来睡眠ポリグラフ（PSG）システム市場：エンドユーザー別

• 概要
• 病院
• 睡眠研究所
• 在宅ケア設定

第7章 外来睡眠ポリグラフ（PSG）システム市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• ラテンアメリカ・中東・アフリカ
  • ブラジル
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ
  • その他の地域

第8章 競合情勢

• イントロダクション
• 主要成功戦略
• 主要10企業の製品マッピング
• 競合ダッシュボード
• 競合ヒートマップ
• 主要企業のポジショニング

第9章 企業プロファイル

• Koninklijke Philips N.V.
• Natus Medical Incorporated
• Nihon Kohden Corporation
• Nox Medical
• Lowenstein Medical Technology GmbH+Co. KG.
• neurosoft
• Cadwell Industries Inc.
• SOMNOmedics GmbH
• Compumedics Limited
• Compumedics Limited

LIST OF TABLES

• TABLE 01. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 02. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 12 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
• TABLE 03. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 24 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
• TABLE 04. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 32 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
• TABLE 05. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR ABOVE 32 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
• TABLE 06. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 07. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OBSTRUCTIVE SLEEP, BY REGION, 2021-2031 ($MILLION)
• TABLE 08. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR APNEA NARCOLEPSY, BY REGION, 2021-2031 ($MILLION)
• TABLE 09. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR CHRONIC INSOMNIA, BY REGION, 2021-2031 ($MILLION)
• TABLE 10. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
• TABLE 11. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 12. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
• TABLE 13. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR SLEEP LABORATORIES, BY REGION, 2021-2031 ($MILLION)
• TABLE 14. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021-2031 ($MILLION)
• TABLE 15. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION, 2021-2031 ($MILLION)
• TABLE 16. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 17. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 18. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 19. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
• TABLE 20. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 21. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 22. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 23. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 24. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 25. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 26. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 27. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 28. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 29. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 30. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 31. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 32. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
• TABLE 33. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 34. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 35. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 36. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 37. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 38. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 39. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 40. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 41. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 42. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 43. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 44. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 45. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 46. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 47. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 48. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 49. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 50. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 51. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 52. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 53. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 54. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
• TABLE 55. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 56. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 57. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 58. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 59. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 60. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 61. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 62. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 63. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 64. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 65. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 66. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 67. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 68. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 69. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 70. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 71. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 72. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 73. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 74. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 75. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 76. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
• TABLE 77. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 78. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 79. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 80. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 81. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 82. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 83. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 84. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 85. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 86. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 87. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 88. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 89. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
• TABLE 90. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
• TABLE 91. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
• TABLE 92. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
• TABLE 93. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
• TABLE 94. NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
• TABLE 95. NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
• TABLE 96. NIHON KOHDEN CORPORATION: KEY EXECUTIVES
• TABLE 97. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
• TABLE 98. NOX MEDICAL: KEY EXECUTIVES
• TABLE 99. NOX MEDICAL: COMPANY SNAPSHOT
• TABLE 100. LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: KEY EXECUTIVES
• TABLE 101. LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: COMPANY SNAPSHOT
• TABLE 102. NEUROSOFT: KEY EXECUTIVES
• TABLE 103. NEUROSOFT: COMPANY SNAPSHOT
• TABLE 104. CADWELL INDUSTRIES INC.: KEY EXECUTIVES
• TABLE 105. CADWELL INDUSTRIES INC.: COMPANY SNAPSHOT
• TABLE 106. SOMNOMEDICS GMBH: KEY EXECUTIVES
• TABLE 107. SOMNOMEDICS GMBH: COMPANY SNAPSHOT
• TABLE 108. COMPUMEDICS LIMITED: KEY EXECUTIVES
• TABLE 109. COMPUMEDICS LIMITED: COMPANY SNAPSHOT
• TABLE 110. COMPUMEDICS LIMITED: KEY EXECUTIVES
• TABLE 111. COMPUMEDICS LIMITED: COMPANY SNAPSHOT

LIST OF FIGURES

• FIGURE 01. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031
• FIGURE 02. SEGMENTATION OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031
• FIGURE 03. TOP INVESTMENT POCKETS IN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET (2022-2031)
• FIGURE 04. PORTER FIVE-1
• FIGURE 05. PORTER FIVE-2
• FIGURE 06. PORTER FIVE-3
• FIGURE 07. PORTER FIVE-4
• FIGURE 08. PORTER FIVE-5
• FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALAMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
• FIGURE 10. IMPACT OF KEY REGULATION: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
• FIGURE 11. MARKET SHARE ANALYSIS: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
• FIGURE 12. PATENT ANALYSIS BY COMPANY
• FIGURE 13. PATENT ANALYSIS BY COUNTRY
• FIGURE 14. REGULATORY GUIDELINES: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
• FIGURE 15. VALUE CHAIN ANALYSIS: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
• FIGURE 16. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021(%)
• FIGURE 17. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 12 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
• FIGURE 18. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 24 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
• FIGURE 19. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 32 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
• FIGURE 20. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR ABOVE 32 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
• FIGURE 21. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021(%)
• FIGURE 22. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OBSTRUCTIVE SLEEP, BY COUNTRY 2021 AND 2031(%)
• FIGURE 23. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR APNEA NARCOLEPSY, BY COUNTRY 2021 AND 2031(%)
• FIGURE 24. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR CHRONIC INSOMNIA, BY COUNTRY 2021 AND 2031(%)
• FIGURE 25. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
• FIGURE 26. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021(%)
• FIGURE 27. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)
• FIGURE 28. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR SLEEP LABORATORIES, BY COUNTRY 2021 AND 2031(%)
• FIGURE 29. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY 2021 AND 2031(%)
• FIGURE 30. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET BY REGION, 2021
• FIGURE 31. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 32. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 33. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 34. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 35. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 36. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 37. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 38. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 39. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 40. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 41. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 42. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 43. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 44. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 45. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 46. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 47. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 48. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 49. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 50. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
• FIGURE 51. TOP WINNING STRATEGIES, BY YEAR
• FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT
• FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY
• FIGURE 54. PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 55. COMPETITIVE DASHBOARD
• FIGURE 56. COMPETITIVE HEATMAP: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
• FIGURE 57. TOP PLAYER POSITIONING, 2021

According to a new report published by Allied Market Research, titled, "Ambulatory Polysomnography (Psg) Systems Market," The ambulatory polysomnography (psg) systems market was valued at $327.00 million in 2021, and is estimated to reach $570.7 million by 2031, growing at a CAGR of 6% from 2022 to 2031.

Ambulatory polysomnography (Amb-PSG), also known as type II PSG, can be used to identify different sleep disorders by characterizing sleep stages and quantifying arousals, total sleep time (TST), and an accurate respiratory disturbance index (RDI). Ambulatory polysomnography systems are in high demand among patients suffering from a variety of sleep disorders due to the benefits they provide. This is propelling the ambulatory polysomnography systems market.

The majority of the population, particularly in rural regions, is uninformed of the dangers of sleep apnea. Sleep disorders that go untreated can lead to chronic ailments like heart failure, stroke, high blood pressure, diabetes, and obesity. This can result in major health issues such as uncontrolled blood pressure, heart attacks, weakened and restricted blood vessels in the kidneys, and aneurysms. The population's lack of awareness about sleeping difficulties is expected to stymie the growth of the ambulatory polysomnography systems market in the near future.

Technological improvements in the sleep care business can be identified as a driving force in this market. The ambulatory polysomnography systems market is growing steadily due to numerous revolutionary technologies such as portable devices, smartphone applications, telemedicine, and so on. Wireless and portable polysomnography systems, like as Nox Medical's Nox A1s PSG, have benefited from research and development. Wireless capabilities give patients with a sense of liberty by allowing them freedom of movement while they are being diagnosed. This will have a beneficial impact on the growth of the ambulatory polysomnography systems market.

The global market has benefited by the outbreak of the COVID-19 pandemic. Key participants claimed considerable revenue growth as a result of an increase in the number of patients suffering from sleep difficulties as a result of the COVID19 pandemic. According to the poll, 70% of respondents have experienced one or more new sleep issues since the start of the COVID-19, leading to an increase in the use of sleep apnea equipment. As a result of this, the PSG systems' businesses launched a clinically certified, low-touch CPAP Mask Selector tool that can be utilized remotely from the patient's home.

The key players profiled in this report include: Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, Nox Medical, Lowenstein Medical Technology GmbH + Co. KG., neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, and Neurovirtual / Sleepvirtual.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ambulatory polysomnography (psg) systems market analysis from 2021 to 2031 to identify the prevailing ambulatory polysomnography (psg) systems market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the ambulatory polysomnography (psg) systems market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global ambulatory polysomnography (psg) systems market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

• Up to 12 Channel PSG Systems
• Up to 24 Channel PSG Systems
• Up to 32 Channel PSG Systems
• Above 32 Channel PSG Systems

By Application

• Obstructive Sleep
• Apnea Narcolepsy
• Chronic Insomnia
• Others

By End-user

• Hospitals
• Sleep Laboratories
• Home Care Settings

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • United Arab Emirates
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Cadwell Industries Inc.
• Compumedics Limited
• Compumedics Limited
• Koninklijke Philips N.V.
• Lowenstein Medical Technology GmbH + Co. KG.
• Natus Medical Incorporated
• neurosoft
• Nihon Kohden Corporation
• Nox Medical
• SOMNOmedics GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
• 3.4. Market dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities
• 3.5. COVID-19 Impact Analysis on the market
• 3.6. Average Selling Price
• 3.7. Brand Share Analysis
• 3.8. Key Regulation Analysis
• 3.9. Market Share Analysis
• 3.10. Patent Landscape
• 3.11. Regulatory Guidelines
• 3.12. Value Chain Analysis

CHAPTER 4: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Up to 12 Channel PSG Systems
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Up to 24 Channel PSG Systems
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Up to 32 Channel PSG Systems
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
• 4.5. Above 32 Channel PSG Systems
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country

CHAPTER 5: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Obstructive Sleep
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Apnea Narcolepsy
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Chronic Insomnia
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Others
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country

CHAPTER 6: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Sleep Laboratories
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Home Care Settings
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key trends and opportunities
  • 7.2.2. Market size and forecast, by Product
  • 7.2.3. Market size and forecast, by Application
  • 7.2.4. Market size and forecast, by End-user
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Key market trends, growth factors and opportunities
    • 7.2.5.1.2. Market size and forecast, by Product
    • 7.2.5.1.3. Market size and forecast, by Application
    • 7.2.5.1.4. Market size and forecast, by End-user
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Key market trends, growth factors and opportunities
    • 7.2.5.2.2. Market size and forecast, by Product
    • 7.2.5.2.3. Market size and forecast, by Application
    • 7.2.5.2.4. Market size and forecast, by End-user
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Key market trends, growth factors and opportunities
    • 7.2.5.3.2. Market size and forecast, by Product
    • 7.2.5.3.3. Market size and forecast, by Application
    • 7.2.5.3.4. Market size and forecast, by End-user
• 7.3. Europe
  • 7.3.1. Key trends and opportunities
  • 7.3.2. Market size and forecast, by Product
  • 7.3.3. Market size and forecast, by Application
  • 7.3.4. Market size and forecast, by End-user
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Key market trends, growth factors and opportunities
    • 7.3.5.1.2. Market size and forecast, by Product
    • 7.3.5.1.3. Market size and forecast, by Application
    • 7.3.5.1.4. Market size and forecast, by End-user
    • 7.3.5.2. UK
    • 7.3.5.2.1. Key market trends, growth factors and opportunities
    • 7.3.5.2.2. Market size and forecast, by Product
    • 7.3.5.2.3. Market size and forecast, by Application
    • 7.3.5.2.4. Market size and forecast, by End-user
    • 7.3.5.3. France
    • 7.3.5.3.1. Key market trends, growth factors and opportunities
    • 7.3.5.3.2. Market size and forecast, by Product
    • 7.3.5.3.3. Market size and forecast, by Application
    • 7.3.5.3.4. Market size and forecast, by End-user
    • 7.3.5.4. Spain
    • 7.3.5.4.1. Key market trends, growth factors and opportunities
    • 7.3.5.4.2. Market size and forecast, by Product
    • 7.3.5.4.3. Market size and forecast, by Application
    • 7.3.5.4.4. Market size and forecast, by End-user
    • 7.3.5.5. Italy
    • 7.3.5.5.1. Key market trends, growth factors and opportunities
    • 7.3.5.5.2. Market size and forecast, by Product
    • 7.3.5.5.3. Market size and forecast, by Application
    • 7.3.5.5.4. Market size and forecast, by End-user
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Key market trends, growth factors and opportunities
    • 7.3.5.6.2. Market size and forecast, by Product
    • 7.3.5.6.3. Market size and forecast, by Application
    • 7.3.5.6.4. Market size and forecast, by End-user
• 7.4. Asia-Pacific
  • 7.4.1. Key trends and opportunities
  • 7.4.2. Market size and forecast, by Product
  • 7.4.3. Market size and forecast, by Application
  • 7.4.4. Market size and forecast, by End-user
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. China
    • 7.4.5.1.1. Key market trends, growth factors and opportunities
    • 7.4.5.1.2. Market size and forecast, by Product
    • 7.4.5.1.3. Market size and forecast, by Application
    • 7.4.5.1.4. Market size and forecast, by End-user
    • 7.4.5.2. Japan
    • 7.4.5.2.1. Key market trends, growth factors and opportunities
    • 7.4.5.2.2. Market size and forecast, by Product
    • 7.4.5.2.3. Market size and forecast, by Application
    • 7.4.5.2.4. Market size and forecast, by End-user
    • 7.4.5.3. India
    • 7.4.5.3.1. Key market trends, growth factors and opportunities
    • 7.4.5.3.2. Market size and forecast, by Product
    • 7.4.5.3.3. Market size and forecast, by Application
    • 7.4.5.3.4. Market size and forecast, by End-user
    • 7.4.5.4. South Korea
    • 7.4.5.4.1. Key market trends, growth factors and opportunities
    • 7.4.5.4.2. Market size and forecast, by Product
    • 7.4.5.4.3. Market size and forecast, by Application
    • 7.4.5.4.4. Market size and forecast, by End-user
    • 7.4.5.5. Australia
    • 7.4.5.5.1. Key market trends, growth factors and opportunities
    • 7.4.5.5.2. Market size and forecast, by Product
    • 7.4.5.5.3. Market size and forecast, by Application
    • 7.4.5.5.4. Market size and forecast, by End-user
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Key market trends, growth factors and opportunities
    • 7.4.5.6.2. Market size and forecast, by Product
    • 7.4.5.6.3. Market size and forecast, by Application
    • 7.4.5.6.4. Market size and forecast, by End-user
• 7.5. LAMEA
  • 7.5.1. Key trends and opportunities
  • 7.5.2. Market size and forecast, by Product
  • 7.5.3. Market size and forecast, by Application
  • 7.5.4. Market size and forecast, by End-user
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Key market trends, growth factors and opportunities
    • 7.5.5.1.2. Market size and forecast, by Product
    • 7.5.5.1.3. Market size and forecast, by Application
    • 7.5.5.1.4. Market size and forecast, by End-user
    • 7.5.5.2. United Arab Emirates
    • 7.5.5.2.1. Key market trends, growth factors and opportunities
    • 7.5.5.2.2. Market size and forecast, by Product
    • 7.5.5.2.3. Market size and forecast, by Application
    • 7.5.5.2.4. Market size and forecast, by End-user
    • 7.5.5.3. Saudi Arabia
    • 7.5.5.3.1. Key market trends, growth factors and opportunities
    • 7.5.5.3.2. Market size and forecast, by Product
    • 7.5.5.3.3. Market size and forecast, by Application
    • 7.5.5.3.4. Market size and forecast, by End-user
    • 7.5.5.4. South Africa
    • 7.5.5.4.1. Key market trends, growth factors and opportunities
    • 7.5.5.4.2. Market size and forecast, by Product
    • 7.5.5.4.3. Market size and forecast, by Application
    • 7.5.5.4.4. Market size and forecast, by End-user
    • 7.5.5.5. Rest of LAMEA
    • 7.5.5.5.1. Key market trends, growth factors and opportunities
    • 7.5.5.5.2. Market size and forecast, by Product
    • 7.5.5.5.3. Market size and forecast, by Application
    • 7.5.5.5.4. Market size and forecast, by End-user

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

• 9.1. Koninklijke Philips N.V.
  • 9.1.1. Company overview
  • 9.1.2. Key Executives
  • 9.1.3. Company snapshot
• 9.2. Natus Medical Incorporated
  • 9.2.1. Company overview
  • 9.2.2. Key Executives
  • 9.2.3. Company snapshot
• 9.3. Nihon Kohden Corporation
  • 9.3.1. Company overview
  • 9.3.2. Key Executives
  • 9.3.3. Company snapshot
• 9.4. Nox Medical
  • 9.4.1. Company overview
  • 9.4.2. Key Executives
  • 9.4.3. Company snapshot
• 9.5. Lowenstein Medical Technology GmbH + Co. KG.
  • 9.5.1. Company overview
  • 9.5.2. Key Executives
  • 9.5.3. Company snapshot
• 9.6. neurosoft
  • 9.6.1. Company overview
  • 9.6.2. Key Executives
  • 9.6.3. Company snapshot
• 9.7. Cadwell Industries Inc.
  • 9.7.1. Company overview
  • 9.7.2. Key Executives
  • 9.7.3. Company snapshot
• 9.8. SOMNOmedics GmbH
  • 9.8.1. Company overview
  • 9.8.2. Key Executives
  • 9.8.3. Company snapshot
• 9.9. Compumedics Limited
  • 9.9.1. Company overview
  • 9.9.2. Key Executives
  • 9.9.3. Company snapshot
• 9.10. Compumedics Limited
  • 9.10.1. Company overview
  • 9.10.2. Key Executives
  • 9.10.3. Company snapshot